CANDRIAM S.C.A. – Denali Therapeutics Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$10.98M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+4.28%
quarter
Denali Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.84% | 34.99K shares | 1.48M | $30.69 | 357.87K |
| Q2 2022 | share | Increase | +128.17% | 181.37K shares | 4.95M | $29.43 | 322.88K |
| Q1 2022 | share | 0.00% | 0 shares | -1.75M | $32.17 | 141.50K | |
| Q4 2021 | share | Increase | +121.86% | 77.72K shares | 3.09M | $45.05 | 141.50K |
| Q3 2021 | share | 0.00% | 0 shares | -1.78M | $50.45 | 63.78K | |
| Q2 2021 | share | Increase | 0.00% | 63.78K shares | 5.00M | $78.44 | 63.78K |